{
 "drug": "Emtricitabine Capsule",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "06/17/2026",
 "dayN": 69,
 "cat": "Anti-Infective",
 "companies": [
  "Gilead Sciences, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "06/17/2026",
   "update_type": "New",
   "initial_posting_date": "06/17/2026",
   "package_ndc": "61958-0601-1",
   "generic_name": "Emtricitabine Capsule",
   "contact_info": "800-445-3235",
   "related_info": "Product expected to be available until March 2027",
   "openfda": {
    "application_number": [
     "NDA021500"
    ],
    "brand_name": [
     "EMTRIVA"
    ],
    "generic_name": [
     "EMTRICITABINE"
    ],
    "manufacturer_name": [
     "Gilead Sciences, Inc."
    ],
    "product_ndc": [
     "61958-0601",
     "61958-0602"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "EMTRICITABINE"
    ],
    "rxcui": [
     "403875",
     "404587",
     "597291",
     "616148"
    ],
    "spl_id": [
     "13ed3577-67a4-4828-b886-f35206f149a6"
    ],
    "spl_set_id": [
     "d6599395-3944-44f9-97f2-e0424c6b6a1f"
    ],
    "package_ndc": [
     "61958-0601-1",
     "61958-0602-1"
    ],
    "nui": [
     "N0000175462",
     "M0015066",
     "N0000009947"
    ],
    "pharm_class_epc": [
     "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_cs": [
     "Nucleosides [CS]"
    ],
    "pharm_class_moa": [
     "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "unii": [
     "G70B4ETF4S"
    ]
   },
   "update_date": "06/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Capsule",
   "presentation": "Emtriva, Capsule, 200 mg (NDC 61958-0601-1)",
   "company_name": "Gilead Sciences, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}